Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabio Mascella

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
International Journal of Immunopathology and Pharmacology|May 27, 2016
Aromatase inhibitors and anti-synthetase syndromeFabio Mascella, Lorenzo Gianni, Alessandra Affatato, et al.
Igiene E Sanita Pubblica|September 6, 2007
[Methodological problems associated with the planning of.]Lamberto Manzoli, Fabio Mascella, Marina Fratini, et al.
Pharmacology|June 29, 2018
Effective Desensitization to Tocilizumab in Delayed Hypersensitivity ReactionGabriele Cortellini, Fabio Mascella, Margherita Simoncelli, et al.
Clinical and Experimental Rheumatology|February 19, 2013
Does early arthritis clinic organisation improve outcomes? What evidence is there? A systematic reviewMarcello Govoni, Carlo Alberto Sciré, Maria Manara, et al.
Frontiers in Medicine|January 6, 2023
Residual inflammation in psoriatic arthritis patients in stable minimal disease activityPierluigi Macchioni, Antonio Marchesoni, Giovanni Ciancio, et al.
Joint Bone Spine|February 27, 2025
Clinical and ultrasonographic predictors of disease activity after TNF-α inhibitor spacing in patients with psoriatic arthritisAntonio Marchesoni, Pierluigi Macchioni, Giovanni Ciancio, et al.
Journal of Clinical Medicine|March 14, 2026
Exploring Disease-Specific Risk Factors for Vertebral Fractures in Systemic Sclerosis: Insights from the ScleroRER Study GroupAlessandra Bezzi, Federica Lumetti, Martina Orlandi, et al.
Medicina (Kaunas, Lithuania)|August 26, 2023
Long-Term Retention Rate of Tofacitinib in Rheumatoid Arthritis: An Italian Multicenter Retrospective Cohort StudyMarino Paroli, Andrea Becciolini, Elena Bravi, et al.
BMC Rheumatology|November 25, 2025
Comparative effectiveness of cycling versus swapping to IL-17 inhibitors after first TNF inhibitor failure in Psoriatic Arthritis: A real-world multicenter studyAlarico Ariani, Maddalena Larosa, Alberto Lo Gullo, et al.
Minerva Medica|October 8, 2024
Multicenter observational study on the efficacy of selective Janus Kinase-1 inhibitor upatacitinib in rheumatoid arthritisAlberto Lo Gullo, Simone Parisi, Andrea Becciolini, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
International Journal of Immunopathology and Pharmacology|May 27, 2016
Aromatase inhibitors and anti-synthetase syndromeFabio Mascella, Lorenzo Gianni, Alessandra Affatato, et al.
Igiene E Sanita Pubblica|September 6, 2007
[Methodological problems associated with the planning of.]Lamberto Manzoli, Fabio Mascella, Marina Fratini, et al.
Pharmacology|June 29, 2018
Effective Desensitization to Tocilizumab in Delayed Hypersensitivity ReactionGabriele Cortellini, Fabio Mascella, Margherita Simoncelli, et al.
Clinical and Experimental Rheumatology|February 19, 2013
Does early arthritis clinic organisation improve outcomes? What evidence is there? A systematic reviewMarcello Govoni, Carlo Alberto Sciré, Maria Manara, et al.
Frontiers in Medicine|January 6, 2023
Residual inflammation in psoriatic arthritis patients in stable minimal disease activityPierluigi Macchioni, Antonio Marchesoni, Giovanni Ciancio, et al.
Joint Bone Spine|February 27, 2025
Clinical and ultrasonographic predictors of disease activity after TNF-α inhibitor spacing in patients with psoriatic arthritisAntonio Marchesoni, Pierluigi Macchioni, Giovanni Ciancio, et al.
Journal of Clinical Medicine|March 14, 2026
Exploring Disease-Specific Risk Factors for Vertebral Fractures in Systemic Sclerosis: Insights from the ScleroRER Study GroupAlessandra Bezzi, Federica Lumetti, Martina Orlandi, et al.
Medicina (Kaunas, Lithuania)|August 26, 2023
Long-Term Retention Rate of Tofacitinib in Rheumatoid Arthritis: An Italian Multicenter Retrospective Cohort StudyMarino Paroli, Andrea Becciolini, Elena Bravi, et al.
BMC Rheumatology|November 25, 2025
Comparative effectiveness of cycling versus swapping to IL-17 inhibitors after first TNF inhibitor failure in Psoriatic Arthritis: A real-world multicenter studyAlarico Ariani, Maddalena Larosa, Alberto Lo Gullo, et al.
Minerva Medica|October 8, 2024
Multicenter observational study on the efficacy of selective Janus Kinase-1 inhibitor upatacitinib in rheumatoid arthritisAlberto Lo Gullo, Simone Parisi, Andrea Becciolini, et al.
Pageof 2